Paliperidone

Chemical formula: C₂₃H₂₇FN₄O₃  Molecular mass: 426.484 g/mol  PubChem compound: 115237

Therapeutic indications

Paliperidone is indicated for:

Schizophrenia

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Schizophrenia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Schizoaffective disorder

Population group: only adults (18 - 65 years old)

Schizoaffective disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Paliperidone is contraindicated in the following cases:

Lactation

Lactation

Severe renal impairment with creatinine clearance below 10 mL/min

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Risperidone

Risperidone

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: INVEGA Prolonged-release tablet
Summary of Product Characteristics (SPC) 2021: XEPLION Prolonged release suspension for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈